107 related articles for article (PubMed ID: 4039564)
1. Partial purification and characterization of the tissue plasminogen activator in nasal mucosa and nasal polyp.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Biochem Med; 1985 Feb; 33(1):117-23. PubMed ID: 4039564
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
3. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
Heussen C; Joubert F; Dowdle EB
J Biol Chem; 1984 Oct; 259(19):11635-8. PubMed ID: 6541221
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Thromb Haemost; 1985 Aug; 54(2):485-9. PubMed ID: 3936218
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator.
Nolan C; Hall LS; Barlow GH; Tribby II
Biochim Biophys Acta; 1977 Feb; 496(2):384-400. PubMed ID: 836903
[TBL] [Abstract][Full Text] [Related]
6. A plasminogen activator from benign ovarian cystadenoma: partial purification and characterization.
Cheung A; Lau HK; Yuen P
Thromb Res; 1986 Mar; 41(5):717-29. PubMed ID: 3961743
[TBL] [Abstract][Full Text] [Related]
7. [Investigation on the expression of microvessel pericyte coverage index and lymph vessel density in nasal polyps].
Cui N; Zhu DD; Guan GM; Sha JC; Meng CD; Li L; Xiu Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):923-928. PubMed ID: 27978883
[No Abstract] [Full Text] [Related]
8. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa.
Jung TT; Juhn SK; Hwang D; Stewart R
Laryngoscope; 1987 Feb; 97(2):184-9. PubMed ID: 3027479
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen-activator in human early milk: its partial purification and characterization.
Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
[TBL] [Abstract][Full Text] [Related]
10. Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.
Xu R; Li Y; Xie M; Xu G; Zhang G; Wang S
Chin Med J (Engl); 2002 Sep; 115(9):1386-9. PubMed ID: 12411119
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a plasminogen activator produced by Acanthamoeba castellanii.
Mitra MM; Alizadeh H; Gerard RD; Niederkorn JY
Mol Biochem Parasitol; 1995 Jul; 73(1-2):157-64. PubMed ID: 8577323
[TBL] [Abstract][Full Text] [Related]
12. Purification and partial characterization of plasminogen activator from human uterine tissue.
Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
[TBL] [Abstract][Full Text] [Related]
13. [The concentration and expression of IL-5 in human nasal polyp tissue].
Xu R; Li Y; Xie M; Xu G; Zhang G; Wang S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Aug; 35(4):251-4. PubMed ID: 12768697
[TBL] [Abstract][Full Text] [Related]
14. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
15. Differences in physicochemical properties between tissue plasminogen activators from human paranasal mucous membrane and pig heart.
Kosugi T; Takagi I; Matsuo O; Mihara H; Morimitsu T; Hirano K; Hamaya M
Auris Nasus Larynx; 1981; 8(2):77-86. PubMed ID: 7199907
[TBL] [Abstract][Full Text] [Related]
16. Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp.
Lee SH; Kim WS; Lee SH; Oh JW; Lee HM; Jung HH; Jang JW; Jun YJ; Cho WJ; Jhun HS
Acta Otolaryngol; 2005 Aug; 125(8):877-82. PubMed ID: 16158536
[TBL] [Abstract][Full Text] [Related]
17. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.
Levin EG
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6804-8. PubMed ID: 6580616
[TBL] [Abstract][Full Text] [Related]
18. Purification and properties of a plasminogen activator from pig heart.
Cole ER; Bachmann FW
J Biol Chem; 1977 Jun; 252(11):3729-37. PubMed ID: 863901
[TBL] [Abstract][Full Text] [Related]
19. Partial purification and characterization of native plasminogen activators from bovine milk.
Deharveng G; Nielsen SS
J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
[TBL] [Abstract][Full Text] [Related]
20. [Expression of prolactin in macrophage of nasal polyps and its significance].
Guan B; Dong Z; Yang ZQ; Guan GM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):531-3. PubMed ID: 15606001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
